Bicara Therapeutics | 10-Q:季度报表
Bicara Therapeutics | 8-K:Bicara Therapeutics公布2024年第三季度财务业绩并提供业务最新情况
Bicara Therapeutics | SC 13G:超过5%持股股东披露文件-Raymond Debbane(5.7%),Invus Public Equities, L.P.(5.6%)等
Bicara Therapeutics | SC 13G:超过5%持股股东披露文件-Red Tree Venture Fund, L.P.(5.8%),Red Tree GP, LLC(5.8%)等
Bicara Therapeutics | SC 13D:超过5%持股股东披露文件-RA Capital Management, L.P.(12.8%),Peter Kolchinsky(12.8%)等
Bicara Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Bicara Therapeutics | SC 13D:超过5%持股股东披露文件-TPG GP A, LLC(5.5%),David Bonderman(5.5%)等
Bicara Therapeutics | 4:持股变动声明- TPG GP A, LLC
Bicara Therapeutics | SC 13G:超过5%持股股东披露文件-FMR LLC(5.095%),Abigail P. Johnson(5.095%)
Bicara Therapeutics | 4:持股变动声明- FIL Ltd
Bicara Therapeutics | 4:持股变动声明- FMR LLC
Bicara Therapeutics | 4:持股变动声明-股东 Flynn James E
Bicara Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Bicara Therapeutics | 4:持股变动声明-董事 LONBERG NILS
Bicara Therapeutics | 4:持股变动声明-董事 Simson Jake
Bicara Therapeutics | 4:持股变动声明-股东 Biocon Ltd
Bicara Therapeutics | 4:持股变动声明-董事 Haviland Kate
Bicara Therapeutics | 4:持股变动声明-董事 Mazumdar-Shaw Kiran
Bicara Therapeutics | 4:持股变动声明-董事 Robertson Scott M.
Bicara Therapeutics | 8-K:重大事件
暂无数据